Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
CASTLIGHT HEALTH, INC. (CSLT)
|
Add to portfolio |
|
|
|
| Price: |
$1.65
| | Metrics |
| OS: |
162.1
|
M
| |
|
|
| Market cap: |
$268
|
M
| |
|
|
|
Net cash:
|
$65.8
|
M
| |
$0.41
|
per share
|
|
EV:
|
$202
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 146.7 | 143.3 | 156.4 | 156.4 | 132.0 | 98.7 | 150.6 | 45.6 |
| Revenue growth | 2.4% | -8.4% | 18.5% | | 33.7% | -34.5% | 230.3% | 251.5% |
| Cost of goods sold | 52.0 | 59.1 | 60.2 | 60.2 | 46.7 | 31.9 | 33.8 | 27.8 |
| Gross profit | 94.7 | 84.2 | 96.2 | 96.2 | 85.4 | 66.8 | 116.9 | 17.8 |
| Gross margin | 64.5% | 58.8% | 61.5% | 61.5% | 64.7% | 67.7% | 77.6% | 39.1% |
| Sales and marketing | 32.0 | 38.6 | 49.1 | 49.1 | 59.8 | 58.6 | 67.4 | 62.1 |
| Research and development | 49.5 | 59.0 | 61.4 | 61.4 | 54.5 | 40.5 | 30.1 | 22.9 |
| General and administrative | 25.7 | 28.0 | 25.6 | 25.6 | 28.8 | 26.9 | 24.3 | 19.0 |
| EBITA | -8.3 | -37.3 | -35.9 | -39.9 | -54.1 | -59.1 | -80.2 | -86.2 |
| EBITA margin | -5.6% | -26.1% | -22.9% | -25.5% | -41.0% | -59.9% | -53.3% | -188.9% |
| Amortization of intangibles | 4.2 | 4.0 | 4.0 | | 3.6 | | | |
| EBIT | -12.5 | -41.3 | -39.9 | -39.9 | -57.7 | -59.1 | -80.2 | -86.2 |
| EBIT margin | -8.5% | -28.8% | -25.5% | -25.5% | -43.7% | -59.9% | -53.3% | -188.9% |
| Pre-tax income | -62.2 | -40.0 | -39.7 | -39.7 | -57.1 | -58.7 | -79.9 | -85.9 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | -5.2 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 9.1% | 0.0% | 0.0% | 0.0% |
| Net income | -62.2 | -40.0 | -39.7 | -39.7 | -51.9 | -58.7 | -79.9 | -85.9 |
| Net margin | -42.4% | -27.9% | -25.4% | -25.4% | -39.3% | -59.5% | -53.1% | -188.4% |
| |
| Diluted EPS | ($0.41) | ($0.28) | ($0.29) | ($0.29) | ($0.41) | ($0.58) | ($852.45) | ($1.16) |
| Shares outstanding (diluted) | 151.5 | 145.2 | 137.7 | 137.7 | 125.5 | 100.8 | 0.1 | 74.4 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|